Premier Inc.Acquired by Patient Square Capital in $2.6 Billion Deal
Premier Inc., a leading provider of healthcare technology adn services, has been acquired by Patient Square Capital, a healthcare-focused investment firm. This transition marks the end of Premier’s decade-long run as a publicly traded company on Nasdaq.
Key Takeaways
* Premier stockholders will receive $28.25 in cash for each share held.
* The acquisition values the company at a ample $2.6 billion.
* The deal closed ahead of schedule, surpassing initial expectations of a first-quarter 2026 completion.
A New Chapter for Premier
Premier will now function as a wholly owned subsidiary of patient Square Capital.This change follows a period of strategic evaluation for Premier,initiated in 2023,as the company navigated financial challenges and evolving market dynamics.
The company’s board of directors has resigned as part of the agreement. However, Michael Alkire, the current CEO, and Glenn Coleman, the CFO, will continue to serve as directors, ensuring continuity in leadership.
Addressing Recent Challenges
Recent financial reports revealed a decline in Premier’s revenue and net income. Revenue for the quarter ending September 30th reached $240 million, a 3% decrease year-over-year. Net income from continuing operations also fell significantly, dropping 79% to $15.3 million compared to the previous year.
To address these headwinds, Premier has strategically divested certain assets. These include its non-healthcare group purchasing operations,generating approximately $800 million in cash,and its holdings in S2S Global,a healthcare and foodservice company. Moreover, the company is in the process of winding down operations at Contigo Health, its employee health benefits subsidiary.
Patient Square’s Expanding Healthcare Portfolio
Patient Square Capital has been actively building a robust portfolio of healthcare companies. Their existing investments include ChenMed, a value-based primary care provider; Access Telecare, specializing in acute care telemedicine; and CorroHealth, a revenue cycle management firm.
This acquisition of Premier aligns with Patient Square’s strategy of investing in companies that drive innovation and efficiency within the healthcare industry. You can expect to see synergies and collaborative efforts between Premier and Patient Square’s other portfolio companies in the future.
This acquisition represents a notable shift for Premier, offering new opportunities for growth and innovation under the guidance of Patient Square Capital. It’s a advancement worth watching as it unfolds and potentially reshapes the landscape of healthcare technology and services.